Sunshine Biopharma News

8-K: Current report

Apr 24 04:11

Sunshine Biopharma | 8-K: Current report

Apr 2 02:32

Sunshine Biopharma | 10-K: Annual report

Mar 29 04:10

Sunshine Biopharma | DEF 14C: Definitive information statements

Mar 15 23:16

Sunshine Biopharma | 8-K: Current report

Mar 7 05:12

Sunshine Biopharma | PRE 14C: Preliminary information statement not related to a contested matter or merger/acquisition

Mar 6 05:43

Sunshine Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Slilaty Steve N.

Mar 6 05:10

Sunshine Biopharma | DEF 14C: Definitive information statements

Mar 6 00:40

Sunshine Biopharma | 8-K: Current report

Mar 2 05:25

Sunshine Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-L1 Capital Global Opportunities Master Fund, Ltd.(5.3%)

Feb 24 05:06

Sunshine Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Altium Capital Management, LP EIN:(9.99%),Altium Growth Fund, LP EIN:(9.99%), etc.

Feb 22 05:32

Sunshine Biopharma | PRE 14C: Preliminary information statement not related to a contested matter or merger/acquisition

Feb 21 21:26

Sunshine Biopharma | 8-K: Current report

Feb 17 06:03

Sunshine Biopharma | 8-K: Current report

Feb 16 00:42

Sunshine Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(7.60%),Steven Boyd(7.60%)

Feb 15 04:57

Sunshine Biopharma | 424B4: Prospectus

Feb 15 00:22

Sunshine Biopharma | EFFECT: Others

Feb 13 19:04

Sunshine Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Slilaty Steve N.

Feb 13 05:14

Sunshine Biopharma | 8-K: Current report

Feb 12 22:09

Sunshine Biopharma | CORRESP: CORRESP

Feb 10 11:19